share_log

Baird Maintains Neutral on Edwards Lifesciences, Lowers Price Target to $68

Benzinga ·  Oct 25 08:17  · Ratings

Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and lowers the price target from $73 to $68.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment